Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in leukemia

Por um escritor misterioso

Descrição

Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Co-inhibition of HDAC and MLL-menin interaction targets MLL
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Recent Progress of Small Molecule Menin–MLL Interaction Inhibitors
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
IJMS, Free Full-Text
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Discovery of M-1121 as an Orally Active Covalent Inhibitor of
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
APExBIO - MI-2 (hydrochloride) menin-MLL interaction inhibitor
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Challenges and opportunities in targeting the menin–MLL
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Transcriptional activation by MLL fusion proteins in
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Therapeutic implications of menin inhibition in acute leukemias
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
APExBIO - MI-2, Menin-MLL Inhibitor
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
MI-2-2 exhibits pronounced activity in MV4;11 human leukemia cells
Menin-MLL inhibitors reverse oncogenic activity of MLL fusion proteins in  leukemia
Disordered epigenetic regulation in MLL-related leukemia
de por adulto (o preço varia de acordo com o tamanho do grupo)